Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Sunday. Get Kestra Medical Technologies alerts:View Our Latest Research Report on KMTSKestra Medical Technologies Stock Down 3.8%Institutional Investors Weigh In On Kestra Medical TechnologiesKMTS opened at $23.41 on Friday. Kestra Medical Technologies has a 1-year low of $13.25 and a 1-year high of $27.71. Finally, Virtu Financial LLC bought a new stake in Kestra Medical Technologies in the 1st quarter worth about $210,000. Read MoreReceive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.